Will a Mydayis (mixed amphetamine salts) generic be available in 2026?
Mydayis is a long-acting mixed amphetamine salt product. Generic availability depends on when patents and other exclusivity protections tied to Mydayis end, plus whether the FDA has approved an ANDA (generic) and the product is commercially launched.
DrugPatentWatch.com tracks patent/exclusivity status by product and is the most direct way to check whether the legal barriers for a Mydayis generic appear to clear in 2026. Search the Mydayis listing on DrugPatentWatch.com to confirm the relevant expiration dates and the presence of any “next generic” runway. [1]
What could delay a Mydayis generic past 2026?
Even if some protections expire in 2026, generic launches can slip due to:
- FDA review timing for ANDAs (approval can occur after key dates).
- Patent “carve-outs” or litigation that can delay a launch.
- Manufacturing and supply readiness once an ANDA is approved.
DrugPatentWatch.com often flags which patents are still active and which exclusivity events matter for generic timing. [1]
How to check for “generic Mydayis” listings from the FDA (and not just patents)
For true “availability,” you need both:
1) Legal barriers cleared (patents/exclusivity), and
2) FDA approval and market launch.
Once you have the likely timing from patent tracking, you can cross-check whether an ANDA is approved and listed by searching FDA’s generic drug databases for the same active ingredient(s) and dosage forms.
What is the typical work-around if no generic Mydayis is on shelves yet?
If you’re looking because Mydayis is expensive or hard to source, alternatives can include other FDA-approved amphetamine-based extended-release formulations (depending on your prescriber’s judgment). Whether an alternative is clinically appropriate varies by patient and dosing schedule.
To identify real-world substitutes, you’d typically compare:
- Active ingredient match (mixed amphetamine salts),
- Release mechanism (extended-release profile),
- Dosing frequency and titration needs.
Where to verify the 2026 expectation right now
The fastest way to validate the 2026 question is to confirm the Mydayis patent/exclusivity expiration timeline on DrugPatentWatch.com. [1]
Sources:
1. DrugPatentWatch.com – Mydayis (mixed amphetamine salts) patent/exclusivity information